In this article, we describe a pharmacogenetics solution which allows to selectively and reversibly inactivate LC neurons using Designer Receptors Completely Activated by Designer Drugs (DREADD). We present which the expression of the hM4Di DREADD may be limited to noradrenergic LC neurons and that the level of LC inhibition is https://freshchesms.com/product/buy-deschloroetizolam-2mg-blotters/